Genopathy
Gene-Disorder Association · Article
Gene
MET
MET Proto-Oncogene, Receptor Tyrosine Kinase
Disorder
Prostate Cancer
First reported 1995
Supporting publications 10
Key publication · gene–disorder Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.The American journal of pathology · 1995
Key publication · disorder Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.Journal of the American Medical Association · 1950
Manually curated
Association Review

In brief

The association between MET (MET Proto-Oncogene, Receptor Tyrosine Kinase) and Prostate Cancer is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 5
Compounds 0
Trials 0
Publications 10
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MET

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Prostate Cancer

The disorder

20 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Literature

Reading

10 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
07
Provenance

References & sources

16 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access